The Role of Apolipoprotein E in Alzheimer's Disease
Top Cited Papers
- 1 August 2009
- Vol. 63 (3) , 287-303
- https://doi.org/10.1016/j.neuron.2009.06.026
Abstract
No abstract availableKeywords
Funding Information
- American Health Assistance Foundation
- National Institutes of Health (AG13956)
This publication has 245 references indexed in Scilit:
- Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factorsThe Lancet Neurology, 2008
- ApoE Promotes the Proteolytic Degradation of AβNeuron, 2008
- Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In VivoNeuron, 2008
- APOE genotype-specific differences in the innate immune responsePublished by Elsevier ,2007
- Amyloid Precursor Protein Regulates Brain Apolipoprotein E and Cholesterol Metabolism through Lipoprotein Receptor LRP1Neuron, 2007
- Neuronal LR11/sorLA expression is reduced in mild cognitive impairmentAnnals of Neurology, 2007
- Versatility in ligand recognition by LDL receptor family proteins: advances and frontiersCurrent Opinion in Structural Biology, 2007
- Loss of Apolipoprotein E Receptor LR11 in Alzheimer DiseaseArchives of Neurology, 2004
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993